Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LYEL · as of Jun 9, 2026
Key Statistics
Explore Lyell Immunopharma, Inc. Data
lyel stock data · financialsCompetitors & Peers
lyel competitorsLYEL
ACIU
ALDX
ALLO
AMRN
CABAAbout Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. (LYEL) is a firm specializing in T cell reprogramming, dedicated to crafting T cell therapies for individuals battling solid tumors. The company's therapeutic innovation relie…
what is lyell immunopharma, inc. · lyel stock overview · lyell immunopharma, inc. company profile · who is lyell immunopharma, inc. ceo · lyel NASDAQ · lyell immunopharma, inc. headquarters · lyell immunopharma, inc. business segments
About Stock Overview & Key Data
Lyell Immunopharma, Inc. (LYEL) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 17, 2021. As of the latest trading session, LYEL stock price is $12.31, with a market capitalization of $287.2M. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Lyell Immunopharma, Inc. (LYEL) stock price is $12.31. The stock is traded on NASDAQ under the ticker symbol LYEL. The 52-week range is $8.46 – $45.00.